Skip to Content

Join the 'Paroxysmal Nocturnal Hemoglobinuria' group to help and get support from people like you.

Paroxysmal Nocturnal Hemoglobinuria News

FDA Medwatch Alert: Soliris (Eculizumab) Concentrated Solution for Intravenous Infusion by Alexion: Recall - Visible Particles

Posted 16 Dec 2013 by

ISSUE: Alexion Pharmaceuticals, Inc. is providing information regarding a previously communicated voluntary recall of two lots of Soliris (eculizumab) Concentrated Solution for Intravenous Infusion. As stated on Nov. 12, 2013, the two lots were found to contain visible particles. At that time, Alexion provided instructions to return any unused vials of Soliris from these two lots at the distributor level. Alexion is now providing the same instructions at the hospital/user level. The administration of particulate, if present in a parenteral drug, poses a potential safety risk to patients in two general areas: immunogenicity and thromboembolic events. Particulates could cause blockage of flow of blood in vessels, which could be life-threatening. To date, there have been no product complaints of particulates, or identifiable safety concerns attributed to the product consumed from the ... Read more

Related support groups: Soliris, Paroxysmal Nocturnal Hemoglobinuria, Eculizumab

Ask a Question

Further Information

Related Drug Support Groups

Soliris, eculizumab